Circulation, Vol 69, 973-982, Copyright © 1984 by American Heart Association
EE Buttner, RB Karp, JG Reves, S Oparil, C Brummett, HG McDaniel, LR Smith and G Kreusch
To determine whether adding blood to a cardioplegic solution affects
myocardial preservation, a randomized prospective study was carried out in
60 patients undergoing coronary revascularization to compare the effects of
crystalloid potassium cardioplegics (group C) and potassium cardioplegic
solutions to which blood has been added (group B) on markers of myocardial
metabolism (lactate, inorganic phosphate, base deficit release, glucose and
lactate uptake, oxygen extraction), myocardial damage (creatine kinase
[CK]-MB levels), and cardiac performance (cardiac index and left atrial
pressure). The solution with added blood had a significantly (p less than
.05) greater oxygen content, a lower pH, and higher concentrations of
potassium, calcium, sodium, and glucose. In group B patients there was a
suggestion (p less than .06) of greater uptake of oxygen during the
beginning of the initial cardioplegic infusion. During reperfusion there
was no evidence of differential release of the metabolites of anaerobiosis
and myocardial oxygen extraction and glucose and lactate uptake were
similarly depressed in both groups. Likewise, CK-MB release after bypass
was the same in both groups. Prompt, adequate functional recovery of
cardiac index and left atrial pressure was observed in both groups. It was
concluded that although there may be more oxygen available from the
blood-containing solution during early infusion, there is no evidence that
under the conditions of this investigation adding blood to cardioplegic
solution improves myocardial preservation.
ARTICLES
A randomized comparison of crystalloid and blood-containing cardioplegic solutions in 60 patients
This article has been cited by other articles:
![]() |
J. T. Bjerrum, M. J. Perko, and B. Beck Myocardial oxygen tension during surgical revascularization: A clinical comparison between blood cardioplegia and crystalloid cardioplegia Eur. J. Cardiothorac. Surg., February 1, 2006; 29(2): 181 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Ibrahim, G. E. Venn, C. P. Young, and D. J. Chambers A clinical comparative study between crystalloid and blood-based St Thomas' hospital cardioplegic solution Eur. J. Cardiothorac. Surg., January 1, 1999; 15(1): 75 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Wang, A. Stamler, M. Tofukuji, T. E. Deuson, and F. W. Sellke Effects of Blood and Crystalloid Cardioplegia on Adrenergic and Myogenic Vascular Mechanisms Ann. Thorac. Surg., January 1, 1997; 63(1): 41 - 49. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1984 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |